Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto Effect on Sympathetic Nervous System in Heart Failure
NCT02787798Phase 4Terminated
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Oct 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Sympathetic Nervous System Activity at 8 weeks. Started Oct 2016; status: terminated.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02787798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787798.